{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:37:27Z","timestamp":1792712247105,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Kechuang Medical Development Foundation"},{"name":"Natural Science Foundation of Shaanxi Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16595-x","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:55:11Z","timestamp":1784984111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic features and prognostic factors of breast cancer brain metastases patients based on molecular subtypes: a real-world retrospective analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Shidi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"16595_CR1","unstructured":"(IARC) IAfRoC. Global Cancer Observatory. 2024. https:\/\/gco.iarc.fr\/. Accessed February 13, 2024."},{"key":"16595_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447\u201356. https:\/\/doi.org\/10.1093\/neuonc\/noab101.","journal-title":"Neuro Oncol"},{"key":"16595_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","volume":"14","author":"L Nayak","year":"2012","unstructured":"Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14:48\u201354. https:\/\/doi.org\/10.1007\/s11912-011-0203-y.","journal-title":"Curr Oncol Rep"},{"key":"16595_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-015-0028-8","volume":"4","author":"JP Leone","year":"2015","unstructured":"Leone JP, Leone BA. Breast cancer brain metastases: the last frontier. Exp Hematol Oncol. 2015;4:33. https:\/\/doi.org\/10.1186\/s40164-015-0028-8.","journal-title":"Exp Hematol Oncol"},{"key":"16595_CR5","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.asjsur.2021.12.037","volume":"45","author":"MS Sun","year":"2022","unstructured":"Sun MS, Yun YY, Liu HJ, Yu ZH, Yang F, Xu L. Brain metastasis in de novo breast cancer: An updated population-level study from SEER database. Asian J Surg. 2022;45:2259\u201367. https:\/\/doi.org\/10.1016\/j.asjsur.2021.12.037.","journal-title":"Asian J Surg"},{"key":"16595_CR6","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/jco.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271\u20137. https:\/\/doi.org\/10.1200\/jco.2009.25.9820.","journal-title":"J Clin Oncol"},{"key":"16595_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","volume":"31","author":"F Cardoso","year":"2020","unstructured":"Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, Andre F, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31:1623\u201349. https:\/\/doi.org\/10.1016\/j.annonc.2020.09.010.","journal-title":"Ann Oncol"},{"key":"16595_CR8","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","volume":"23","author":"M Kuksis","year":"2021","unstructured":"Kuksis M, Gao Y, Tran W, Hoey C, Kiss A, Komorowski AS, et al. The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro Oncol. 2021;23:894\u2013904. https:\/\/doi.org\/10.1093\/neuonc\/noaa285.","journal-title":"Neuro Oncol"},{"key":"16595_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41416-019-0619-y","volume":"121","author":"A Darlix","year":"2019","unstructured":"Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, Debled M, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019;121:991\u20131000. https:\/\/doi.org\/10.1038\/s41416-019-0619-y.","journal-title":"Br J Cancer"},{"key":"16595_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/bf01053937","volume":"15","author":"W Boogerd","year":"1993","unstructured":"Boogerd W, Vos VW, Hart AA, Baris G. Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol. 1993;15:165\u201374. https:\/\/doi.org\/10.1007\/bf01053937.","journal-title":"J Neurooncol"},{"key":"16595_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/neuonc\/noaa013","volume":"22","author":"AFC Hulsbergen","year":"2020","unstructured":"Hulsbergen AFC, Claes A, Kavouridis VK, Ansaripour A, Nogarede C, Hughes ME, et al. Subtype switching in breast cancer brain metastases: a multicenter analysis. Neuro Oncol. 2020;22:1173\u201381. https:\/\/doi.org\/10.1093\/neuonc\/noaa013.","journal-title":"Neuro Oncol"},{"key":"16595_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/neuonc\/noaa025","volume":"22","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Estrogen\/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. Neuro Oncol. 2020;22:1359\u201367. https:\/\/doi.org\/10.1093\/neuonc\/noaa025.","journal-title":"Neuro Oncol"},{"key":"16595_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejca.2019.11.001","volume":"125","author":"D Pasquier","year":"2020","unstructured":"Pasquier D, Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, et al. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. Eur J Cancer. 2020;125:22\u201330. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.001.","journal-title":"Eur J Cancer"},{"key":"16595_CR14","doi-asserted-by":"publisher","first-page":"e000440","DOI":"10.1136\/esmoopen-2018-000440","volume":"3","author":"C Maurer","year":"2018","unstructured":"Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, et al. Risk factors for the development of brain metastases in patients with HER2-positive breast cancer. ESMO Open. 2018;3:e000440. https:\/\/doi.org\/10.1136\/esmoopen-2018-000440.","journal-title":"ESMO Open"},{"key":"16595_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22:331\u201357. https:\/\/doi.org\/10.6004\/jnccn.2024.0035.","journal-title":"J Natl Compr Canc Netw"},{"key":"16595_CR16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","volume":"32","author":"A Gennari","year":"2021","unstructured":"Gennari A, Andr\u00e9 F, Barrios CH, Cort\u00e9s J, de Azambuja E, DeMichele A, et al. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol. 2021;32:1475\u201395. https:\/\/doi.org\/10.1016\/j.annonc.2021.09.019.","journal-title":"Ann Oncol"},{"key":"16595_CR17","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/jco.22.00520","volume":"40","author":"N Ramakrishna","year":"2022","unstructured":"Ramakrishna N, Anders CK, Lin NU, Morikawa A, Temin S, Chandarlapaty S, et al. Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update. J Clin Oncol. 2022;40:2636\u201355. https:\/\/doi.org\/10.1200\/jco.22.00520.","journal-title":"J Clin Oncol"},{"key":"16595_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","volume":"17","author":"JH Suh","year":"2020","unstructured":"Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sahgal A, Chang EL. Current approaches to the management of brain metastases. Nat Rev Clin Oncol. 2020;17:279\u201399. https:\/\/doi.org\/10.1038\/s41571-019-0320-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"16595_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3892\/ol.2017.6166","volume":"14","author":"NE Oehrlich","year":"2017","unstructured":"Oehrlich NE, Spineli LM, Papendorf F, Park-Simon TW. Clinical outcome of brain metastases differs significantly among breast cancer subtypes. Oncol Lett. 2017;14:194\u2013200. https:\/\/doi.org\/10.3892\/ol.2017.6166.","journal-title":"Oncol Lett"},{"key":"16595_CR20","doi-asserted-by":"publisher","unstructured":"Wang T, Zhang H, Li F, Wu X, Zhou J, Zhang S, et al. Abstract P1-21-04: The real word study on clinical features and prognostic factors of Chinese breast cancer patients with brain metastasis. Cancer Res. 2022;82. https:\/\/doi.org\/10.1158\/1538-7445.Sabcs21-p1-21-04. :P1-21-04-P1-21-04.","DOI":"10.1158\/1538-7445.Sabcs21-p1-21-04"},{"key":"16595_CR21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-25-3557","author":"G Griguolo","year":"2026","unstructured":"Griguolo G, Bottosso M, Landa G, Bonomi G, Miglietta F, Guarascio MC, et al. Proactive brain screening using contrast-enhanced brain CT scans in HER2\u2009+\u2009metastatic breast cancer. Clin Cancer Res. 2026. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-25-3557.","journal-title":"Clin Cancer Res"},{"key":"16595_CR22","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/s1470-2045(20)30556-8","volume":"22","author":"AJ Morgan","year":"2021","unstructured":"Morgan AJ, Giannoudis A, Palmieri C. The genomic landscape of breast cancer brain metastases: a systematic review. Lancet Oncol. 2021;22:e7\u201317. https:\/\/doi.org\/10.1016\/s1470-2045(20)30556-8.","journal-title":"Lancet Oncol"},{"key":"16595_CR23","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00432-018-2697-2","volume":"144","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Kim JS, Kim IA. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database. J Cancer Res Clin Oncol. 2018;144:1803\u201316. https:\/\/doi.org\/10.1007\/s00432-018-2697-2.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16595_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12885-018-4371-0","volume":"18","author":"J Jin","year":"2018","unstructured":"Jin J, Gao Y, Zhang J, Wang L, Wang B, Cao J, et al. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer. BMC Cancer. 2018;18:446. https:\/\/doi.org\/10.1186\/s12885-018-4371-0.","journal-title":"BMC Cancer"},{"key":"16595_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","volume":"135","author":"MA Franzoi","year":"2019","unstructured":"Franzoi MA, Hortobagyi GN. Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol. 2019;135:85\u201394. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.020.","journal-title":"Crit Rev Oncol Hematol"},{"key":"16595_CR26","doi-asserted-by":"publisher","unstructured":"Scandurra G, Lombardo V, Scibilia G, Sambataro D, Gebbia V, Scollo P et al. New Frontiers in the Treatment of Patients with HER2\u2009+\u2009Cancer and Brain Metastases: Is Radiotherapy Always Useful? Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/cancers16132466.","DOI":"10.3390\/cancers16132466"},{"key":"16595_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/jco.2017.75.9589","volume":"36","author":"PD Brown","year":"2018","unstructured":"Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V. Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? J Clin Oncol. 2018;36:483\u201391. https:\/\/doi.org\/10.1200\/jco.2017.75.9589.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16595-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:37:44Z","timestamp":1792708664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16595-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16595"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16595-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University (approval number: XJTU1AF2020LSK-277). Given the retrospective nature of the study, the requirement for informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Unanimous agreement has been reached.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1275"}}